NCT00905346View on ClinicalTrials.gov

Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Healthy
Interventions
DRUG

Topiramate 25 mg Capsules

Topiramate Capsules 2 x 25 mg

DRUG

Topamax® 25 mg Capsules

Topamax® Capsule 2 x 25 mg

OTHER

Applesauce

Applesauce

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00905346 - Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions | Biotech Hunter | Biotech Hunter